Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
US FDA Observation
Insider Trades
|
Turnaround Potential
1323.0000
11.60
(
0.88
%)
NSE
Sep 18, 2025
15:30 PM
29.71% Gain from 52W Low
Volume:
821.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
29 Jun 2022
US FDA Observation
Insider Trades
1323.00
0.88%
Company Update:Dr Reddys Labs
Buy:
Dr. Reddy's Laboratories Ltd.
by
Axis Direct
Target: 4750
Target
Axis Direct
We recommend a BUY rating on the stock with a TP of Rs 4,750.
Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
More from Dr. Reddy's Laboratories Ltd.
Recommended
Market trades higher, Capacit'e Infra bags Rs 1,518 crore realty order
Trendlyne Marketwatch |
18 Sep 2025, 03:27PM
From gems to gadgets: India’s $24 billion leap into global smartphone manufacturing
The Baseline |
17 Sep 2025, 06:26PM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021, 11:13AM